RecruitingNCT04995640

CILCA Arch Registry: Management and Outcomes of Open and Endovascular Repair

CILCA Registry: Aortic Arch Variant With a Common Origin of the Innominate and Left Carotid Artery. Management and Outcomes of Open and Endovascular Repair.

Sponsor

Ospedale San Donato

Enrollment

500 participants

Start Date

Oct 1, 2021

Study Type

OBSERVATIONAL

Conditions

Aortic Diseases Aortic Arch Bovine Arch

Summary

This registry aims to provide insights on the pathogenic mechanisms that expose subjects with CILCA arch to the increased risk of postoperative complications. So, the CILCA arch registry will capture clinical data and medical images of subjects with CILCA arch treated by surgical or endovascular (TEVAR) means. Study Design: International Multicenter and Observational registry Estimated Enrolment: 500 patients, with competitive enrolment. Clinical Follow up: Postoperatively at 30 days, at 12 months, and yearly after.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This is a registry study tracking outcomes for patients who have an aortic disease (such as aortic dissection or aneurysm) affecting a specific part of the aorta called the CILCA arch, and who are treated with either open surgery or minimally invasive (endovascular) repair. You may be eligible if: - You are 18 years of age or older - You have a CILCA arch (a specific anatomical variant of the aorta) treated for aortic disease such as dissection or aneurysm You may NOT be eligible if: - You have contraindications to CT scanning (allergy to contrast dye, kidney failure) - You are pregnant or suspected to be pregnant Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.